Abstract
Purpose
The 5th Heidelberg Myeloma Workshop was held on April 24 and 25, 2015, in the lecture hall of the department of internal medicine of the University Hospital of Heidelberg, Germany.
Methods and Results
Main topics of the meeting were (1) new insights into biology of plasma cell diseases, (2) familial risk in multiple myeloma (MM), (3) diagnosis and prognostic factors in MM and early plasma cell diseases, (4) frontline therapy in transplant-eligible and (5) transplant-ineligible patients as well as (6) treatment of relapsed disease.
Conclusion
Better understanding of disease biology led to tremendous changes in the treatment of multiple myeloma in recent years and were reported during the meeting.
Similar content being viewed by others
Conflict of interest
None.
Human and animal rights
This work does not include human participants or animals.
Informed consent
Informed consent was obtained from all individual participants included in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Merz, M., Hillengass, J. & Goldschmidt, H. Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma. J Cancer Res Clin Oncol 142, 247–251 (2016). https://doi.org/10.1007/s00432-015-1993-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-015-1993-3